[1] |
Nguyen L, Sharma A, Chakraborty C, et al. Review of prospects of biological fluid biomarkers in osteoarthritis[J]. Int J Mol Sci, 2017, 18: 601. doi: 10.3390/ijms18030601.
|
[2] |
Rousseau JC, Chapurlat R, Garnero P. Soluble biological markers in osteoarthritis[J]. Ther Adv Musculoskelet Dis, 2021, 13: 1759720X211040300. doi: 10.1177/1759720X211040300.
|
[3] |
Pollard B, Johnston M, Dixon D. Exploring differential item functioning in the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)[J]. BMC Musculoskelet Disord, 2012, 13:265. doi: 10.1186/1471-2474-13-265.
|
[4] |
Ding C, Zhang Y, Hunter D. Use of imaging techniques to predict progression in osteoarthritis[J]. Curr Opin Rheumatol, 2013, 25:127-135. doi: 10.1097/BOR.0b013e32835a0fe1.
|
[5] |
Kraus VB, Karsdal MA. Clinical monitoring in osteoarthritis: Biomarkers[J]. Osteoarthr Cartilage, 2022, 30: 1159-1173. doi: 10.1016/j.joca.2021.04.019.
|
[6] |
van Spil W, Szilagyi I. Osteoarthritis year in review 2019: biomarkers (biochemical markers)[J]. Osteoarthr Cartilage, 2020, 28:296-315. doi: 10.1016/j.joca.2019.11.007.
|
[7] |
Garnero P, Conrozier T, Christgau S, et al. Urinary type Ⅱ collagen C-telopeptide levels are increased in patients with rapidly destructive hip osteoarthritis[J]. Ann Rheum Dis, 2003, 62:939-943. doi: 10.1136/ard.62.10.939.
|
[8] |
Verma P, Dalal K. Serum cartilage oligomeric matrix protein (COMP) in knee osteoarthritis: a novel diagnostic and prognostic biomarker[J]. J Orthop Res, 2013, 31:999-1006. doi: 10.1002/jor.22324.
|
[9] |
Fernandes FA, Pucinelli ML, da Silva NP, et al. Serum cartilage oligomeric matrix protein (COMP) levels in knee osteoarthritis in a Brazilian population: clinical and radiological correlation[J]. Scand J Rheumatol, 2007, 36:211-215. doi: 10.1080/03009740601154186.
|
[10] |
刘琳琳,傅捷,张树明,等. IL-6联合 MMP-3在早期诊断骨性关节炎中表达及临床意义[J]. 中国实验诊断学,2017,21:273-276.
|
[11] |
Sharif M, Kirwan J, Charni N, et al. A 5-yr longitudinal study of type ⅡA collagen synthesis and total type Ⅱ collagen degradation in patients with knee osteoarthritis--association with disease progression[J]. Rheumatology, 2007, 46:938-943. doi: 10.1093/rheumatology/kel409.
|
[12] |
Kraus V, Collins J, Hargrove D, et al. Predictive validity of biochemical biomarkers in knee osteoarthritis: data from the FNIH OA Biomarkers Consortium[J]. Ann Rheum Dis, 2017, 76:186-195. doi: 10.1136/annrheumdis-2016-209252.
|